SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/A024B40F00825BACFE5B0A1D16808E0AEAAFDB927978D0439284723D1031E2224DDCBA1003C7F5249B3A5E04A4C2B0DE>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/A024B40F00825BACFE5B0A1D16808E0AEAAFDB927978D0439284723D1031E2224DDCBA1003C7F5249B3A5E04A4C2B0DE
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/A024B40F00825BACFE5B0A1D16808E0AEAAFDB927978D0439284723D1031E2224DDCBA1003C7F5249B3A5E04A4C2B0DE
http://www.w3.org/2000/01/rdf-schema#comment
"Suppression of PPARgamma in highly malignant prostate cancer cells produced a significant reduction (up to 53%) in their proliferation rate invasiveness (up to 89%) and anchorage-independent growth (up to 94%) in vitro."
xsd:string
http://purl.uniprot.org/uniprot/#_855BC4D067C23A235C4A60024AAA263F8A8235460C0420E2BF3D0ADB1DCA846C3289DCC0443A049C09C63AFF35A1677A
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/A024B40F00825BACFE5B0A1D16808E0AEAAFDB927978D0439284723D1031E2224DDCBA1003C7F5249B3A5E04A4C2B0DE
http://purl.uniprot.org/uniprot/E9PFX5
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/A024B40F00825BACFE5B0A1D16808E0AEAAFDB927978D0439284723D1031E2224DDCBA1003C7F5249B3A5E04A4C2B0DE
http://purl.uniprot.org/uniprot/#_E9PFX5-mappedCitation-26814431
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/A024B40F00825BACFE5B0A1D16808E0AEAAFDB927978D0439284723D1031E2224DDCBA1003C7F5249B3A5E04A4C2B0DE